Skip to Main Content
October 02, 2020

Health Law Weekly

First Circuit Rejects Bid to Require Medicare to Cover Drug That Treats Iron Deficiency

  • October 02, 2020

The First Circuit refused September 30 to direct the Centers for Medicare & Medicaid Services (CMS) to allow Medicare Part D reimbursement of Akebia Pharmaceuticals, Inc.’s drug Auryxia, which is used to treat iron deficiency anemia (IDA) in patients with chronic kidney disease.

You must be logged in to access this content.